Terumo had five patents in artificial intelligence during Q4 2023. Terumo Corp filed patents for an arterial-pressure estimation apparatus, an information processing method for detecting abnormalities in the heart or blood vessels, and a system for assisting in medical operations on organs using ultrasound imaging and learning models to determine puncture lines. GlobalData’s report on Terumo gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Terumo grant share with artificial intelligence as a theme is 20% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Arterial-pressure estimation apparatus, arterial-pressure estimation system, and arterial-pressure estimation method (Patent ID: US20230355116A1)
The patent filed by Terumo Corp. describes an arterial-pressure estimation apparatus that acquires sensor data indicating blood flow timing in a blood vessel downstream of the aorta, records corresponding pressure values, corrects pressure values during inspiration periods, and estimates arterial pressure changes over time. The apparatus can perform weighting based on elapsed time in the inspiration period, set weighting coefficients using invasive examination data, and match pressure reduction timing with the respiration cycle. It can also estimate left ventricular end-diastolic pressure (LVEDP) and generate trained models for LVEDP estimation through machine learning.
Furthermore, the patent includes claims for an arterial-pressure estimation system with a sensor for blood flow detection and an inflation portion for compression, as well as a method for estimating arterial pressure by compressing blood vessels, detecting blood flow, recording pressure values, correcting values during inspiration periods, and estimating pressure changes over time. The method can involve weighting based on inspiration period time, setting weighting coefficients using invasive examination data, and matching pressure reduction timing with the respiration cycle. Additionally, a computer-readable medium storing a program for executing the arterial-pressure estimation process is also claimed in the patent.
To know more about GlobalData’s detailed insights on Terumo, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.